Licensed health care providers; to permit the dispensing of ivermectin by pharmacists without an individual prescription
Summary
HB146 would change Alabama law to allow pharmacists to dispense ivermectin without an individual patient prescription when acting under a standing order issued by a physician, physician assistant, or certified registered nurse practitioner. The standing order would have to include a risk-assessment protocol, a standardized information sheet for patients, and a recordkeeping form documenting the assessment and dosage dispensed. The bill applies to adults 19 and older, and to minors only with written parental or guardian consent.
The bill also creates protections for the health care provider who signs the standing order and for the pharmacist who dispenses ivermectin under it. It bars licensing boards from disciplining those providers solely because ivermectin was dispensed under the standing order, and it limits discipline for pharmacists who in good faith follow, misread, or decline to follow the order. The bill further prohibits providers and pharmacists from accepting inducements to promote ivermectin use, and it states that the measure does not change existing medical malpractice law, pharmacy practice standards, or payer coverage rules. If enacted, it would take effect on October 1, 2026.
Impact
HB146 would amend Alabama’s prescription-drug framework by creating a new exception to the usual requirement that ivermectin be dispensed only on an individual prescription. It would add a statutory process for non-patient-specific standing orders, define who may issue them, and establish conditions for pharmacist dispensing, patient counseling, and documentation. It would also limit the authority of the relevant licensing boards to impose discipline in connection with dispensing under a valid standing order, while preserving existing liability laws and insurance/payment arrangements.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes, the available context suggests the measure is being advanced as a permissive access bill rather than a punitive or restrictive one. The bill’s structure indicates support for pharmacist discretion, provider protection, and patient access to ivermectin under controlled conditions. Because there are no transcripts or vote records provided, there is no documented public opposition or endorsement in the supplied materials, but the bill’s subject matter suggests it may be associated with broader debate over ivermectin use and professional oversight.
Contention
The main points of potential contention are the bill’s authorization of ivermectin dispensing without an individual prescription and the immunity-like protections it gives to prescribers and pharmacists. Supporters would likely emphasize access, flexibility, and protection from board discipline, while critics may object to expanding access to a drug whose use has been controversial and to limiting professional accountability. Another possible point of dispute is the prohibition on inducements to encourage ivermectin use, which reflects concern about promotion or endorsement of the drug. No specific opposing or supporting speakers are identified in the provided record.
Veterinary medicine; veterinarian-client-patient relationship further provided; refilling prescription regulations; relationship shared among a location, provided
Pharmacy Board, continued until October 1, 2026; membership and duties of board revised and penalties for violations revised, pursuant to the Sunset Law